Bill Ackman on Valeant: Mistakes Were Made

(7:14)

Valeant shares continue to plunge

(2:3)

Valeant Shares Soar as Bearish Analyst's Short Thesis Gets Debunked

(47)

Key things investors need to know about Valeant | The Bottom Line

(2:19)

Valeant: Information Vacuums, Management Credibility and Investment Value

(20:41)

The Valeant Fraud Explained

(11:27)

Charlie Munger: Sewer too light a word for Valeant

(4:38)

4 Explosive Growth Stocks I’m Buying in This Inflated Market!

(18:32)

Charlie Munger: Valeant is a Sewer

(2:57)

How to Read a Stock Chart: Beginner's Guide

(30:39)

Most Heated Exchanges: Hedge Fund Giant Bill Ackman And Investor Carl Icahn Square Off | CNBC

(3:49)

2 MUST BUY Growth Stocks Poised for EXPLOSIVE Gains in 2025

(14:53)

BEWARE! META, TSLA, AMZN, MSFT \u0026 AAPL Report Earnings Next Week!

(21:37)

Top 10 Stocks For January 27, 2025 ( $NVNI, $GOEV, $RGTI, $ACON, $NVDA, and more! )

(14:24)

Vale Stock - When To Buy It? NYSE: VALE

(6:16)

Safkhet Capital's Quadir Is Still Short Valeant

(7:39)

Beginning Value Investors BHC Stock Analysis, BLCO spinoff. Bausch + Lomb Bausch Health Valeant

(27:9)

DON'T BUY Hepion Pharmaceuticals Stock (Until You Watch This Analysis) #HEPA

(2:53)

Roddy Boyd on his investigative reporting on Valeant

(8:31)

Jim Cramer Now Sees Value In Drug Stock Valeant After Its CEO ‘Delivered’

(1:58)

Valeant Shares Slid After FDA Raised Red Flags on Drug Manufacturing Plant

(1:)

Valeant Shares Fall on Reports the Company May Sell Some Assets

(23)

Checkmate or Stalemate: Valeant's fall from investing grace

(12:13)

Valeant Falls Below $80 for First Time in Two Years

(2:1econd)

Bill Ackman defends Valeant

(5:3)

Valeant Suffers Biggest Drop on Record, What's Next?

(3:6)

Valeant Pharmaceuticals Shares Tank on Weak Guidance

(1:17)

Strategic Maneuvers in Valeant-Allergan Takeover Battle Continue

(1:36)

Citron Research Founder: What Valeant's Doing 'Sounds Illegal'

(4:5)